EXCEDRIN MIGRAINE is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Acetaminophen; Aspirin; Caffeine.
| Product ID | 0067-2039_34dc47b2-41d4-49ae-abb0-80d04ef55dca |
| NDC | 0067-2039 |
| Product Type | Human Otc Drug |
| Proprietary Name | EXCEDRIN MIGRAINE |
| Generic Name | Acetaminophen, Aspirin (nsaid) And Caffeine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020802 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Active Ingredient Strength | 250 mg/1; mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2010-02-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing End Date | 2014-12-31 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing End Date | 2012-12-31 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing End Date | 2017-07-31 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing End Date | 2014-07-31 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-02-15 |
| Marketing End Date | 2014-12-31 |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-02-15 |
| Marketing End Date | 2012-12-31 |
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| SPL SET ID: | 7ed841fb-a61c-4868-b4e5-4f2311a5e79c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| Pharm Class PE | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52904-871 | Excedrin Migraine | acetaminophen, aspirin, and caffeine |
| 66715-9749 | Excedrin Migraine | acetaminophen, aspirin, and caffeine |
| 0067-2040 | Excedrin Migraine | Excedrin Migraine |
| 0067-2039 | EXCEDRIN | Acetaminophen, Aspirin (NSAID) and Caffeine |
| 0067-8201 | EXCEDRIN | Acetaminophen, Aspirin (NSAID) and Caffeine |
| 53808-0835 | EXCEDRIN | Acetaminophen, Aspirin (NSAID) and Caffeine |
| 67414-239 | EXCEDRIN | Acetaminophen, Aspirin (NSAID) and Caffeine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EXCEDRIN 98594008 not registered Live/Pending |
Haleon CH SARL 2024-06-10 |
![]() EXCEDRIN 97425413 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-05-24 |
![]() EXCEDRIN 97210682 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
![]() EXCEDRIN 97210676 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
![]() EXCEDRIN 86434099 4978864 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2014-10-24 |
![]() EXCEDRIN 85243455 3985911 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2011-02-16 |
![]() EXCEDRIN 74504161 1892912 Dead/Cancelled |
Bristol-Myers Squibb Company 1994-03-23 |
![]() EXCEDRIN 73661685 1472811 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1987-05-18 |
![]() EXCEDRIN 72080162 0696323 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1959-08-25 |